The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
Open accessAbstract
BACKGROUND: Streptococcus pneumoniae is a leading and serious coinfection in adults with human immunodeficiency virus (HIV) infection, particularly in Africa. Prevention of this disease by vaccination with the current 23-valent polysaccharide vaccine is suboptimal. Protein conjugate vaccines offer a further option for protection, but data on their clinical efficacy in adults are needed. METHODS: In this double-blind, randomized, placebo-controlled clinical efficacy trial, we studied the efficacy of a 7-valent conjugate pneumococcal vaccine in predominantly HIV-infected Malawian adolescents and adults who had recovered from documented invasive pneumococcal disease. Two doses of vaccine were given 4 weeks apart. The primary end point was a further episode of pneumococcal infection caused by vaccine serotypes or serotype 6A. RESULTS: From February 2003 through October 2007, we followed 496 patients (of whom 44% were male and 88% were HIV-seropositive) for 798 person-years of observation. There were 67 episodes of pneumococcal disease in 52 patients, all in the HIV-infected subgroup. In 24 patients, there were 19 episodes that were caused by vaccine serotypes and 5 episodes that were caused by the 6A serotype. Of these episodes, 5 occurred in the vaccine group and 19 in the placebo group, for a vaccine efficacy of 74% (95% confidence interval [CI], 30 to 90). There were 73 deaths from any cause in the vaccine group and 63 in the placebo group (hazard ratio in the vaccine group, 1.18; 95% CI, 0.84 to 1.66). The number of serious adverse events within 14 days after vaccination was significantly lower in the vaccine group than in the placebo group (3 vs. 17, P=0.002), and the number of minor adverse events was significantly higher in the vaccine group (41 vs. 13, P=0.003). CONCLUSIONS: The 7-valent pneumococcal conjugate vaccine protected HIV-infected adults from recurrent pneumococcal infection caused by vaccine serotypes or serotype 6A. (Current Controlled Trials number, ISRCTN54494731.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
BLACK, S., SHINEFIELD, H., FIREMAN, B., LEWIS, E., RAY, P., HANSEN, J. R., ELVIN, L., ENSOR, K. M., HACKELL, J., SIBER, G., et al. (2000) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200003000-00003 · Cited by 2,293
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Klugman, K. P., Madhi, S. A., Huebner, R. E., Kohberger, R., Mbelle, N., & Pierce, N. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035060 · Cited by 1,009
Cutts, F., Zaman, S., Enwere, G., Jaffar, S., Levine, O., Okoko, J., Oluwalana, C., Vaughan, A., Obaro, S., Leach, A., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71876-6 · Cited by 900
Clinical Trials : A Methodologic Perspective
Piantadosi, S. (1997) · Cited by 803
Whitney, C. G., Pilishvili, T., Farley, M. M., Schaffner, W., Craig, A. S., Lynfield, R., Nyquist, A.-C., Gershman, K. A., Vazquez, M., Bennett, N. M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69637-2 · Cited by 623
Masur, P. B. H., Kaplan, J. E., & Holmes, K. K. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-5_part_2-200209031-00002 · Cited by 567
French, N., Nakiyingi, J., Carpenter, L., Lugada, E., Watera, C., Moi, K., Moore, M., Antvelink, D., Mulder, D., Janoff, E., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02377-1 · Cited by 461
Self-citationO'Brien, K. L., Moulton, L. H., Reid, R., Weatherholtz, R., Oski, J., Brown, L., Kumar, G., Parkinson, A., Hu, D., Hackell, J., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14022-6 · Cited by 388
Pneumococcal Disease during HIV Infection: Epidemiologic, Clinical, and Immunologic Perspectives
Janoff, E. N., Breiman, R. F., Daley, C. L., & Hopewell, P. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-314 · Cited by 323
Dabis, F. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.07.044248 · Cited by 306
Corticosteroids for Bacterial Meningitis in Adults in Sub-Saharan Africa
Scarborough, M., Gordon, S. B., Whitty, C. J. M., French, N., Njalale, Y., Chitani, A., Peto, T. E. A., Lalloo, D. G., & Zijlstra, E. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065711 · Cited by 281
Self-citationTrue outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi
Kwong-Leung Yu, J. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.037739 · Cited by 234
Gilks, C. F., Ojoo, S. A., Ojoo, J. C., Brindle, R. J., Paul, J., Batchelor, B. I. F., Kimari, J. N., Newnham, R., Bwayo, J., Plummer, F. A., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90076-8 · Cited by 194
Self-citationFlannery, B., Heffernan, R. T., Harrison, L. H., Ray, S. M., Reingold, A. L., Hadler, J., Schaffner, W., Lynfield, R., Thomas, A. R., Li, J., et al. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-144-1-200601030-00004 · Cited by 192
Wildner, M. (1995) · The Journal of Bone and Joint Surgery. British volume · doi:10.1302/0301-620x.77b4.7615617 · Cited by 186
Heffernan, R. T., Barrett, N. L., Gallagher, K. M., Hadler, J. L., Harrison, L. H., Reingold, A. L., Khoshnood, K., Holford, T. R., & Schuchat, A. (2005) · The Journal of Infectious Diseases · doi:10.1086/430356 · Cited by 169
Brichacek, B., Swindells, S., Janoff, E. N., Pirruccello, S., & Stevenson, M. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1191 · Cited by 169
23-valent pneumococcal polysaccharide vaccine. WHO position paper.
(2008) · PubMed · Cited by 143
Grau, I., Pallares, R., Tubau, F., Schulze, M. H., Llopis, F., Podzamczer, D., Liñares, J., & Gudiol, F. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.13.1533 · Cited by 131
Madhi, S. A., Adrian, P. V., Kuwanda, L., et al. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.09.019 · Cited by 125
Klugman, K. P., Madhi, S. A., & Feldman, C. H. (2006) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e328012c5f1 · Cited by 94
Pneumococcal disease in HIV-infected Malawian adults: acute mortality and long-term survival
Gordon, S. B., Chaponda, M., Walsh, A. L., et al. (2002) · AIDS · doi:10.1097/00002030-200207050-00013 · Cited by 74
Self-citationInvasive Pneumococcal Disease in the Immunocompromised Host
Janoff, E. N., & Rubins, J. B. (1997) · Microbial Drug Resistance · doi:10.1089/mdr.1997.3.215 · Cited by 70
Meta-Analysis of the Efficacy of Conjugate Vaccines against Invasive Pneumococcal Disease
Klugman, K. P., Cutts, F. T., Adegbola, R. A., BLACK, S. B., Madhi, S. A., O’Brien, K. L., Santosham, M., Shinefield, H. R., & Sterne, J. A. C. (2014) · ASM Press eBooks · doi:10.1128/9781555815820.ch21 · Cited by 29
Cited by
2013 IDSA Clinical Practice Guideline for Vaccination of the Immunocompromised Host
Rubin, L. G., Levin, M. J., Ljungman, P., Davies, E. G., Avery, R., Tomblyn, M., Bousvaros, A., Dhanireddy, S., Sung, L., Keyserling, H., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/cit684 · Cited by 1,613
Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults
Bonten, M. J. M., Huijts, S. M., Bolkenbaas, M., Webber, C., Patterson, S., Gault, S., van Werkhoven, C. H., van Deursen, A. M. M., Sanders, E. A. M., Verheij, T. J. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1408544 · Cited by 1,248
(2013) · American Journal of Transplantation · doi:10.1111/ajt.12073 · Cited by 687
U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
Griffin, M. R., Zhu, Y., Moore, M. R., Whitney, C. G., & Grijalva, C. G. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1209165 · Cited by 506
Orange, J. S., Ballow, M., Stiehm, E. R., Ballas, Z. K., Chinen, J., De La Morena, M., Kumararatne, D., Harville, T. O., Hesterberg, P., Koleilat, M., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.07.002 · Cited by 456
Metadata
- Authors
- French, N., Gordon, S. B., Mwalukomo, T., White, S. A., Mwafulirwa, G., Longwe, H., Mwaiponya, M., Zijlstra, E. E., Molyneux, M. E., & Gilks, C. F.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2010-03-04
- Volume
- 362
- Issue
- 9
- Pages
- 812-822
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2103351962
- Cited by
- 352
- References
- 27
- FWCI
- 24.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.